ADVFN Logo ADVFN
시장 데이터
뉴스
도구
시장
팔로우

Hot Features

피드 팔로우

Follow Feed 커뮤니티에서 거래자 및 투자자와 연결하세요.

실시간 옵션 플로우

포괄적인 옵션 데이터를 탐색하고 옵션 흐름으로 고급 필터를 사용하세요.

모니터

터미널 모니터로 주식 및 자산 관심 목록을 구성하고 모니터링하세요.
로그인 Premium Icon프리미엄 Help Menu
S&P 500
5,187.70
0.13%
US Tech 100
17,605.60
-0.02%
다우존스 지수
38,884.26
0.08%
Bitcoin
63,009.69
-0.25%
Registration Strip Icon for charts 실시간 차트, 분석 도구 및 가격을 받으려면 등록하세요.
등록
  1. 홈
  2. 인베스팅
  3. 주식
  4. 미국
  5. NASDAQ
  6. Enanta Pharmaceuticals Inc (ENTA)

  7. Enanta Pharmaceuticals Inc (ENTA) 뉴스

ENTA Enanta Pharmaceuticals Inc

13.10
-1.50 (-10.27%)
시간외 거래
최종 업데이트: 06:26:36
15분 지연
기업명 주식 심볼 시장 주식 타입
Enanta Pharmaceuticals Inc ENTA 나스닥 보통주
  가격 변동 가격 변동 % 주식 가격 최근 거래 시간
Upgrade Icon
-1.50 -10.27% 13.10 06:26:36
개장가 저가 고가 종가 전일 종가
11.60 11.60 13.51 13.10 14.60
시세 정보 더보기 »

최근 뉴스

일자 시간 출처 제목
07/05/202420:00BWEnanta Pharmaceuticals to Participate at the JMP Securities..
07/05/202405:05EDGAR2Form 8-K - Current report
07/05/202405:01BWEnanta Pharmaceuticals Reports Financial Results for its..
30/04/202420:10BWEnanta Pharmaceuticals Announces Inducement Grants Under..
30/04/202420:00BWEnanta Pharmaceuticals Announces the Appointment of Matthew..
29/04/202420:00BWEnanta Pharmaceuticals to Host Conference Call on May 6 at..
17/04/202420:00BWEnanta Pharmaceuticals Announces Data Presentation at ESCMID..
09/03/202407:30EDGAR2Form 4 - Statement of changes in beneficial ownership of..
09/03/202407:27EDGAR2Form 4 - Statement of changes in beneficial ownership of..
09/03/202407:23EDGAR2Form 4 - Statement of changes in beneficial ownership of..
09/03/202407:19EDGAR2Form 4 - Statement of changes in beneficial ownership of..
09/03/202407:15EDGAR2Form 4 - Statement of changes in beneficial ownership of..
09/03/202407:12EDGAR2Form 4 - Statement of changes in beneficial ownership of..
06/03/202421:00BWEnanta Pharmaceuticals to Participate at Leerink Partners..
28/02/202408:31EDGAR2Form 4 - Statement of changes in beneficial ownership of..
28/02/202403:11EDGAR2Form SCHEDULE 13G - Statement of acquisition of beneficial..
15/02/202410:23EDGAR2Form 4 - Statement of changes in beneficial ownership of..
15/02/202410:21EDGAR2Form 4 - Statement of changes in beneficial ownership of..
15/02/202410:18EDGAR2Form 4 - Statement of changes in beneficial ownership of..
15/02/202410:15EDGAR2Form 4 - Statement of changes in beneficial ownership of..
15/02/202410:12EDGAR2Form 4 - Statement of changes in beneficial ownership of..
15/02/202410:09EDGAR2Form 4 - Statement of changes in beneficial ownership of..
15/02/202410:00EDGAR2Form 4 - Statement of changes in beneficial ownership of..
15/02/202404:26EDGAR2Form SC 13G/A - Statement of acquisition of beneficial..
09/02/202406:24EDGAR2Form 10-Q - Quarterly report [Sections 13 or 15(d)]
08/02/202406:05EDGAR2Form 8-K - Current report
08/02/202406:01BWEnanta Pharmaceuticals Reports Financial Results for its..
06/02/202421:00BWEnanta Pharmaceuticals to Participate at the Oppenheimer..
31/01/202421:00BWEnanta Pharmaceuticals to Host Conference Call on February 7..
27/01/202406:37EDGAR2Form DEFA14A - Additional definitive proxy soliciting..
27/01/202406:25EDGAR2Form DEF 14A - Other definitive proxy statements
25/01/202407:23EDGAR2Form SC 13G/A - Statement of acquisition of beneficial..
12/01/202406:15EDGAR2Form SC 13G - Statement of acquisition of beneficial..
04/01/202421:00BWEnanta Pharmaceuticals to Provide Updates on its Research..
03/01/202421:00BWEnanta Pharmaceuticals to Present at the 42nd Annual J.P...
27/12/202306:06EDGAR2Form 8-K - Current report
16/12/202310:08EDGAR2Form 4 - Statement of changes in beneficial ownership of..
13/12/202307:16EDGAR2Form 144 - Report of proposed sale of securities
07/12/202310:31EDGAR2Form 4 - Statement of changes in beneficial ownership of..
07/12/202310:29EDGAR2Form 4 - Statement of changes in beneficial ownership of..
07/12/202310:26EDGAR2Form 4 - Statement of changes in beneficial ownership of..
07/12/202310:24EDGAR2Form 4 - Statement of changes in beneficial ownership of..
07/12/202310:22EDGAR2Form 4 - Statement of changes in beneficial ownership of..
07/12/202310:19EDGAR2Form 4 - Statement of changes in beneficial ownership of..
07/12/202310:17EDGAR2Form 4 - Statement of changes in beneficial ownership of..
06/12/202311:24EDGAR2Form 4 - Statement of changes in beneficial ownership of..
06/12/202311:21EDGAR2Form 4 - Statement of changes in beneficial ownership of..
06/12/202311:19EDGAR2Form 4 - Statement of changes in beneficial ownership of..
06/12/202311:15EDGAR2Form 4 - Statement of changes in beneficial ownership of..
06/12/202311:11EDGAR2Form 4 - Statement of changes in beneficial ownership of..

최근 히스토리

NASDAQ
ENTA
Enanta Pharmaceuticals
Delayed Upgrade Clock
ADVFN Logo

대한변국
회사 소개
사업
Popular
앱 받기

도움 및 지원받기: kr-support@advfn.com

ADVFN 서비스 이용은 ADVFN의 이용약관에 동의하는 것입니다 이용약관

© 2024 ADVFN PLC - 모든 권리 보유